Libre, Lance T.

HRN: 20-91-67  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/04/2022
CEFTRIAXONE 1G (VIAL)
07/04/2022
07/10/2022
IV
325mg
Q12
Pcap C
Waiting Final Action 

Indication:  Empirical Escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: